Revenue Summary of AIM ImmunoTech Inc.

AIM ImmunoTech Inc.'s latest annual revenue in 2023 was 202 Thousand USD , up 43.26% from previous year.
AIM ImmunoTech Inc.'s latest quarterly revenue in 2024 Q1 was 40 Thousand USD , down -38.46% from previous quarter.
AIM ImmunoTech Inc. reported a annual revenue of 141 Thousand USD in annual revenue 2022, up 4.44% from previous year.
AIM ImmunoTech Inc. reported a annual revenue of 135 Thousand USD in annual revenue 2021, down -17.18% from previous year.
AIM ImmunoTech Inc. reported a quarterly revenue of 50 Thousand USD for 2024 Q2, up 25.0% from previous quarter.
AIM ImmunoTech Inc. reported a quarterly revenue of 65 Thousand USD for 2023 Q4, up 41.3% from previous quarter.

Annual Revenue Chart of AIM ImmunoTech Inc. (2023 - 1995)

Historical Annual Revenue of AIM ImmunoTech Inc. (2023 - 1995)

Year	Revenue	Revenue Growth
2023	202 Thousand USD	43.26%
2022	141 Thousand USD	4.44%
2021	135 Thousand USD	-17.18%
2020	163 Thousand USD	16.43%
2019	140 Thousand USD	-61.85%
2018	367 Thousand USD	-16.02%
2017	437 Thousand USD	375.0%
2016	92 Thousand USD	-30.83%
2015	133 Thousand USD	-32.49%
2014	197 Thousand USD	31.33%
2013	150 Thousand USD	-29.58%
2012	213 Thousand USD	32.3%
2011	161 Thousand USD	19.26%
2010	135 Thousand USD	21.62%
2009	111 Thousand USD	-58.11%
2008	265 Thousand USD	-74.98%
2007	1.05 Million USD	13.5%
2006	933 Thousand USD	-13.85%
2005	1.08 Million USD	-11.88%
2004	1.22 Million USD	87.06%
2003	657 Thousand USD	92.67%
2002	341 Thousand USD	-12.56%
2001	390 Thousand USD	-50.51%
2000	788 Thousand USD	12.57%
1999	700 Thousand USD	75.0%
1998	400 Thousand USD	33.33%
1997	300 Thousand USD	200.0%
1996	100 Thousand USD	-96.67%
1995	3 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	40 Thousand USD	-38.46%
2024 Q2	50 Thousand USD	25.0%
2023 Q4	65 Thousand USD	41.3%
2023 Q2	42 Thousand USD	-14.29%
2023 Q3	46 Thousand USD	9.52%
2023 Q1	49 Thousand USD	-12.5%
2023 FY	202 Thousand USD	43.26%
2022 Q1	33 Thousand USD	-34.0%
2022 FY	141 Thousand USD	4.44%
2022 Q4	56 Thousand USD	166.67%
2022 Q3	21 Thousand USD	-30.0%
2022 Q2	30 Thousand USD	-9.09%
2021 Q3	33 Thousand USD	43.48%
2021 FY	135 Thousand USD	-17.18%
2021 Q4	50 Thousand USD	51.52%
2021 Q1	28 Thousand USD	-33.33%
2021 Q2	23 Thousand USD	-17.86%
2020 Q2	40 Thousand USD	-11.11%
2020 Q4	42 Thousand USD	16.67%
2020 Q3	36 Thousand USD	-10.0%
2020 FY	163 Thousand USD	16.43%
2020 Q1	45 Thousand USD	-10.0%
2019 Q2	29 Thousand USD	0.0%
2019 Q3	61 Thousand USD	110.34%
2019 FY	140 Thousand USD	-61.85%
2019 Q4	50 Thousand USD	-18.03%
2019 Q1	- USD	-100.0%
2018 Q3	38 Thousand USD	15.15%
2018 Q1	56 Thousand USD	12.0%
2018 Q4	240 Thousand USD	531.58%
2018 FY	367 Thousand USD	-16.02%
2018 Q2	33 Thousand USD	-41.07%
2017 Q2	213 Thousand USD	153.57%
2017 Q4	50 Thousand USD	-44.44%
2017 Q1	84 Thousand USD	425.0%
2017 FY	437 Thousand USD	375.0%
2017 Q3	90 Thousand USD	-57.75%
2016 FY	92 Thousand USD	-30.83%
2016 Q1	39 Thousand USD	44.44%
2016 Q2	15 Thousand USD	-61.54%
2016 Q3	22 Thousand USD	46.67%
2016 Q4	16 Thousand USD	-27.27%
2015 Q3	23 Thousand USD	-51.06%
2015 Q1	36 Thousand USD	-10.0%
2015 Q4	27 Thousand USD	17.39%
2015 Q2	47 Thousand USD	30.56%
2015 FY	133 Thousand USD	-32.49%
2014 Q1	76 Thousand USD	111.11%
2014 Q4	40 Thousand USD	-11.11%
2014 FY	197 Thousand USD	31.33%
2014 Q2	36 Thousand USD	-52.63%
2014 Q3	45 Thousand USD	25.0%
2013 Q1	42 Thousand USD	-20.75%
2013 Q4	36 Thousand USD	0.0%
2013 FY	150 Thousand USD	-29.58%
2013 Q3	36 Thousand USD	0.0%
2013 Q2	36 Thousand USD	-14.29%
2012 Q3	39 Thousand USD	-20.41%
2012 Q2	49 Thousand USD	-31.94%
2012 Q1	72 Thousand USD	89.47%
2012 Q4	53 Thousand USD	35.9%
2012 FY	213 Thousand USD	32.3%
2011 Q3	45 Thousand USD	25.0%
2011 Q2	36 Thousand USD	-14.29%
2011 Q1	42 Thousand USD	55.56%
2011 FY	161 Thousand USD	19.26%
2011 Q4	38 Thousand USD	-15.56%
2010 Q2	41 Thousand USD	28.13%
2010 Q3	35 Thousand USD	-14.63%
2010 Q4	27 Thousand USD	-22.86%
2010 Q1	32 Thousand USD	-20.0%
2010 FY	135 Thousand USD	21.62%
2009 Q4	40 Thousand USD	60.0%
2009 FY	111 Thousand USD	-58.11%
2009 Q1	29 Thousand USD	16.0%
2009 Q2	17 Thousand USD	-41.38%
2009 Q3	25 Thousand USD	47.06%
2008 FY	265 Thousand USD	-74.98%
2008 Q4	25 Thousand USD	47.06%
2008 Q3	17 Thousand USD	13.33%
2008 Q1	208 Thousand USD	-27.02%
2008 Q2	15 Thousand USD	-92.79%
2007 Q2	234 Thousand USD	-8.24%
2007 Q3	285 Thousand USD	21.79%
2007 Q1	255 Thousand USD	16.97%
2007 Q4	285 Thousand USD	0.0%
2007 FY	1.05 Million USD	13.5%
2006 Q3	232 Thousand USD	-6.07%
2006 FY	933 Thousand USD	-13.85%
2006 Q2	247 Thousand USD	4.66%
2006 Q4	218 Thousand USD	-6.03%
2006 Q1	236 Thousand USD	-7.09%
2005 Q1	258 Thousand USD	-19.88%
2005 Q4	254 Thousand USD	-6.27%
2005 FY	1.08 Million USD	-11.88%
2005 Q2	300 Thousand USD	16.28%
2005 Q3	271 Thousand USD	-9.67%
2004 FY	1.22 Million USD	87.06%
2004 Q1	308 Thousand USD	1.65%
2004 Q2	331 Thousand USD	7.47%
2004 Q3	258 Thousand USD	-22.05%
2004 Q4	322 Thousand USD	24.81%
2003 FY	657 Thousand USD	92.67%
2003 Q4	303 Thousand USD	56.19%
2003 Q3	194 Thousand USD	106.38%
2003 Q1	66 Thousand USD	113.61%
2003 Q2	94 Thousand USD	42.42%
2002 Q1	613 Thousand USD	612.79%
2002 Q4	-485 Thousand USD	-713.92%
2002 Q3	79 Thousand USD	-41.04%
2002 Q2	134 Thousand USD	-78.14%
2002 FY	341 Thousand USD	-12.56%
2001 Q2	101 Thousand USD	-20.47%
2001 Q3	76 Thousand USD	-24.75%
2001 Q4	86 Thousand USD	13.16%
2001 FY	390 Thousand USD	-50.51%
2001 Q1	127 Thousand USD	-7.46%
2000 Q3	225.17 Thousand USD	4.48%
2000 FY	788 Thousand USD	12.57%
2000 Q2	215.52 Thousand USD	-29.93%
2000 Q1	307.56 Thousand USD	53.78%
2000 Q4	137.23 Thousand USD	-39.05%
1999 FY	700 Thousand USD	75.0%
1999 Q4	200 Thousand USD	0.0%
1999 Q3	200 Thousand USD	0.0%
1999 Q2	200 Thousand USD	100.0%
1999 Q1	100 Thousand USD	0.0%
1998 Q1	100 Thousand USD	0.0%
1998 Q2	100 Thousand USD	0.0%
1998 Q3	100 Thousand USD	0.0%
1998 FY	400 Thousand USD	33.33%
1998 Q4	100 Thousand USD	0.0%
1997 Q2	100 Thousand USD	0.0%
1997 Q3	100 Thousand USD	0.0%
1997 FY	300 Thousand USD	200.0%
1997 Q4	100 Thousand USD	0.0%
1997 Q1	100 Thousand USD	0.0%
1996 Q1	100 Thousand USD	-88.89%
1996 Q4	- USD	-100.0%
1996 FY	100 Thousand USD	-96.67%
1996 Q3	100 Thousand USD	0.0%
1996 Q2	100 Thousand USD	0.0%
1995 Q4	900 Thousand USD	28.57%
1995 Q3	700 Thousand USD	0.0%
1995 Q1	700 Thousand USD	0.0%
1995 Q2	700 Thousand USD	0.0%
1995 FY	3 Million USD	0.0%

Peer Revenue Comparison of AIM ImmunoTech Inc.

Name	Revenue	Revenue Difference
Ampio Pharmaceuticals, Inc.	- USD	-Infinity%
Armata Pharmaceuticals, Inc.	4.52 Million USD	95.54%
Actinium Pharmaceuticals, Inc.	81 Thousand USD	-149.383%
Azitra, Inc.	686 Thousand USD	70.554%
Can-Fite BioPharma Ltd.	743 Thousand USD	72.813%
Chromocell Therapeutics Corporation	- USD	-Infinity%
Calidi Biotherapeutics, Inc.	- USD	-Infinity%
CEL-SCI Corporation	- USD	-Infinity%
iBio, Inc.	225 Thousand USD	10.222%
Lineage Cell Therapeutics, Inc.	8.94 Million USD	97.742%
MAIA Biotechnology, Inc.	- USD	-Infinity%
Matinas BioPharma Holdings, Inc.	1.09 Million USD	81.569%
Navidea Biopharmaceuticals, Inc.	65.65 Thousand USD	-207.683%
NovaBay Pharmaceuticals, Inc.	14.72 Million USD	98.628%
NanoViricides, Inc.	- USD	-Infinity%
Oragenics, Inc.	37.65 Thousand USD	-436.478%
BiomX Inc.	-357 Thousand USD	156.583%
BiomX Inc.	-357 Thousand USD	156.583%
Protalix BioTherapeutics, Inc.	65.49 Million USD	99.692%
Palatin Technologies, Inc.	4.49 Million USD	95.501%
Scorpius Holdings, Inc.	6.99 Million USD	97.112%

Global Stocks Search

AIM ImmunoTech Inc. (AIM)

Revenue Summary of AIM ImmunoTech Inc.

Annual Revenue Chart of AIM ImmunoTech Inc. (2023 - 1995)

Historical Annual Revenue of AIM ImmunoTech Inc. (2023 - 1995)

Peer Revenue Comparison of AIM ImmunoTech Inc.